Sponsors
The bill strengthens workplace safety and creates uniform, transparent federal drug-testing rules by adding methadone and annual updates, but it raises significant risks to employees using prescribed medications, increases privacy/false-positive concerns, and imposes new costs and implementation burdens on employers and labs.
Federal and transportation employers, passengers, and coworkers: workplace drug panels will explicitly include methadone and be updated regularly to detect newly identified or emerging substances, improving detection of impairment and overall workplace safety.
Federal agencies, DOT-regulated employers, and testing labs: aligning DOT rules with HHS Mandatory Guidelines and standardizing methadone testing creates clearer, more consistent regulatory requirements across federal workplace drug-testing programs, simplifying compliance for multi-modal employers and laboratories.
Federal employees and employers: publishing annual revisions in the Federal Register increases transparency and predictability about which substances are tested and when changes take effect.
Federal and transportation workers (including people receiving medication-assisted treatment): adding methadone and expanding panels will increase positive test results for legitimately prescribed methadone, risking disciplinary action or job loss and deterring employees from seeking or continuing prescribed opioid-use-disorder treatment.
Federal agencies, DOT employers, contractors, and testing labs: implementing methadone testing and yearly updates will create additional administrative, training, equipment, and laboratory-confirmation costs.
Federal and transportation workers: broader and more frequent testing raises privacy concerns and increases the risk of false positives or ambiguous results absent clear confirmatory procedures or medical-exemption protections, potentially leading to unfair penalties.
Based on analysis of 5 sections of legislative text.
Requires HHS to add methadone to federal workplace drug-testing guidelines and mandates DOT to update transportation testing panels; HHS must annually add other substances as needed.
Requires the Department of Health and Human Services (HHS) to add methadone to the federal Mandatory Guidelines for Workplace Drug Testing within 90 days and to annually review and add other substances as needed. Requires the Department of Transportation (DOT) to update its employee drug- and alcohol-testing regulations to include methadone (and any other substances HHS adds) within specified short timelines after HHS publishes final notices.
Introduced March 17, 2026 by Christopher Henry Smith · Last progress March 17, 2026